Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001437749-16-042149
Filing Date
2016-11-15
Accepted
2016-11-15 11:37:03
Documents
1
Period of Report
2016-09-30
Effectiveness Date
2016-11-15

Document Format Files

Seq Description Document Type Size
1 FORM NT 10-Q atrn20161114_nt10q.htm NT 10-Q 29598
  Complete submission text file 0001437749-16-042149.txt   30934
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 161998491
SIC: 7389 Services-Business Services, NEC